KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Other Non-Current Assets: 2014-2024

Historic Other Non-Current Assets for Aurinia Pharmaceuticals (AUPH) over the last 8 years, with Dec 2024 value amounting to $823,000.

  • Aurinia Pharmaceuticals' Other Non-Current Assets fell 89.29% to $93,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $93,000, marking a year-over-year decrease of 89.29%. This contributed to the annual value of $823,000 for FY2024, which is 45.75% down from last year.
  • According to the latest figures from FY2024, Aurinia Pharmaceuticals' Other Non-Current Assets is $823,000, which was down 45.75% from $1.5 million recorded in FY2023.
  • In the past 5 years, Aurinia Pharmaceuticals' Other Non-Current Assets registered a high of $13.3 million during FY2022, and its lowest value of $247,000 during FY2020.
  • In the last 3 years, Aurinia Pharmaceuticals' Other Non-Current Assets had a median value of $1.5 million in 2023 and averaged $5.2 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first surged by 4,692.71% in 2021, then tumbled by 88.63% in 2023.
  • Aurinia Pharmaceuticals' Other Non-Current Assets (Yearly) stood at $247,000 in 2020, then spiked by 4,692.71% to $11.8 million in 2021, then increased by 12.68% to $13.3 million in 2022, then slumped by 88.63% to $1.5 million in 2023, then slumped by 45.75% to $823,000 in 2024.